Cancer Communications

Article	Citations
Issue Information	465
Issue Information	425
	279
	259
Single‐cell transcriptomics and epigenomics point to CD58‐CD2 interaction in controlling primary melanoma growth and immunity	252
Issue Information	219
Nine‐fold variation of risk of advanced colorectal neoplasms according to smoking and polygenic risk score: Results from a cross‐sectional study in a large screening colonoscopy cohort	197
	180
Loss of CDKN1B induces an age‐related clonal hematopoietic disorder via Notch2 activity dysregulation	178
Fascin lysine 471 acetylation cooperates with serine 39 phosphorylation to inhibit actin‐bundling activity and tumor metastasis in esophageal squamous cell carcinoma	162
Defining and tracing subtypes of patient‐derived xenograft models in pancreatic ductal adenocarcinoma	161
Age‐specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross‐sectional study	156
Current status and perspectives of esophageal cancer: a comprehensive review	144
Kindlin‐1 drives early steps of breast cancer metastasis	143
Long‐term survival outcomes and immune checkpoint inhibitor retreatment in patients with advanced cervical cancer treated with camrelizumab plus apatinib in the phase II CLAP study	139
Combined local therapy and CAR‐GPC3 T‐cell therapy in advanced hepatocellular carcinoma: a proof‐of‐concept treatment strategy	137
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of colorectal cancer, 2024 update	133
Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives	113
Issue Information	112
Partial hepatectomy versus interventional treatment in patients with hepatitis B virus‐related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinica	111
P300/CBP‐associated factor (PCAF)‐mediated acetylation of Fascin at lysine 471 inhibits its actin‐bundling activity and tumor metastasis in esophageal cancer	106
Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer	106
Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer	104
Development and validation of an artificial intelligence model for predicting post‐transplant hepatocellular cancer recurrence	102
	101

N6‐methyladenosine‐regulated exosome biogenesis orchestrates an immunosuppressive pre‐metastatic niche in gastric cancer peritoneal metastasis	101
Validation of different personalized risk models of chemotherapy‐induced nausea and vomiting: results of a randomized, double‐blind, phase III trial of fosaprepitant for cancer patients treated with h	98
HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5‐WDR5‐dependent transcriptional program	93
Nasopharyngeal carcinoma treatment paradigm after HK0501 – a potential way forward	93
p38γ and p38δ as biomarkers in the interplay of colon cancer and inflammatory bowel diseases	88
Impact of pre‐existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study	83
Single‐cell transcriptomics provides insights into the origin and immune microenvironment of cervical precancerous lesions	80
Research trends of cancer metabolism: analysis from a Chinese perspective	80
Efficacy and safety of first‐line sintilimab plus anlotinib versus chemotherapy for metastatic non‐small cell lung cancer: a phase II, open‐label, randomized controlled trial	74
	73
Oral transforming growth factor‐beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti‐tumor immunity	69
Comparative single‐cell analysis of esophageal cancer subtypes reveals tumor microenvironment distinctions explaining varied immunotherapy responses	68
Multifunctional inorganic nanomaterials for cancer photoimmunotherapy	65
Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates	61
A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer	59
Issue Information	59
A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX2	51
	51
Cover Image, Volume 45, Issue 6	51
Ubiquitination in cancer: mechanisms and therapeutic opportunities	48
	47
Association of previously irradiated stable brain metastases with outcomes of atezolizumab‐treated non‐small cell lung cancer: A pooled analysis of individual patient data from three randomized trials	47
Cover Image, Volume 42, Issue 1	45
FOXO1 or not FOXO1: that is the question	45
Impact of small molecule‐mediated inhibition of ammonia detoxification on lung malignancies and liver metabolism	44
Targeting IL‐17A to manage immunotherapy‐induced toxicity in melanoma	44
Incidence of and survival with bone and soft tissue sarcoma: A nation‐wide study over four decades	43
Antitumoral effects of cannabis in Notch1‐mutated T‐cell acute lymphoblastic leukemia	43
Comprehensive DSRCT multi‐omics analyses unveil CACNA2D2 as a diagnostic hallmark and super‐enhancer‐driven EWSR1::WT1 signature gene	43
Intercellular communications and metabolic reprogramming as new predictive markers for immunotherapy responses in gastric cancer	43
First‐line serplulimab plus chemotherapy in extensive‐stage small‐cell lung cancer: Updated results and biomarker analysis from the ASTRUM‐005 randomized clinical trial	42
A strong internal promoter drives massive expression of YEATS‐domain devoid MLLT3 transcripts in HSC and most lethal AML	39
Acquired RD3 loss regulates immune surveillance in high‐risk and therapy defying progressive neuroblastoma	38
Association between antipsychotic agents and risk of lung cancer: a nested case‐control study	38
Novel molecular mechanisms of immune evasion in hepatocellular carcinoma: NSUN2‐mediated increase of SOAT2 RNA methylation	38
Harnessing chimeric antigen receptor macrophages against solid tumors	38
Functions and clinical significance of mechanical tumor microenvironment: cancer cell sensing, mechanobiology and metastasis	37
Correction to: ZNF582 hypermethylation promotes metastasis of nasopharyngeal carcinoma by regulating the transcription of adhesion molecules Nectin‐3 and NRXN3	36
An HGF‐dependent positive feedback loop between bladder cancer cells and fibroblasts mediates lymphangiogenesis and lymphatic metastasis	35
Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi‐phased study of prostate cancer	35
Transcriptomic analyses of localized prostate cancers of East Asian and North American men reveal race‐specific luminal‐basal and microenvironmental differences	35
Issue Information	35
Enhanced selection of people for lung cancer screening using AHRR (cg05575921) or F2RL3 (cg03636183) methylation as biological markers of smoking exposure	31
Low household income and income volatility increase risk of lung cancer: A nationwide retrospective cohort study	31
Long‐term outcomes of intraoperative radiotherapy for early‐stage breast cancer in China: a multicenter real‐world study	30
m6A‐modified EHD1 controls PD‐L1 endosomal trafficking to modulate immune evasion and immunotherapy responses in lung adenocarcinoma	30
Transcriptional suppression of CD8+ T cell exhaustion for improving T cell immunotherapy	30
Breast cancer: an up‐to‐date review and future perspectives	29
Development of antibody‐drug conjugates in cancer: Overview and prospects	29
Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract	28

Long‐term antibiotic use and risk of hepatocellular carcinoma later in life: a nationwide cohort study of 9.8 million participants	28
circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer	27
Neuroinflammation drives apathy in cancer cachexia	27
Inhibition of mTOR attenuates the initiation and progression of BRCA1‐associated mammary tumors	26
Genomic information of children with malignant brain tumors for the prediction of length of hospitalization	26
Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine	25
Gene expression profiling improves prognostication by nomogram in patients with soft‐tissue sarcomas	25
4‐1BB transcriptomic expression patterns across malignancies: Implications for clinical trials of 4‐1BB agonists	25
Spatial metabolomics for evaluating response to neoadjuvant therapy in non‐small cell lung cancer patients	25
N‐acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4‐acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA	25
JUPITER‐02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps	25
DNA methylation signature predicts cancer response to demethylation agents from profiling diverse cancer cell lines	24
	24
Lipid metabolism reprograming by SREBP1‐PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy	24
Issue Information	24
Issue Information	24
Pancreatic cancer survival trends in the US from 2001 to 2014: a CONCORD‐3 study	23
Knowing nodal Rouviére: the power of human intelligence in toxicity reduction	23
Sunitinib in metastatic renal cell carcinoma: clinical outcomes across risk groups in a Turkish Oncology Group Kidney Cancer Consortium	23
Single‐cell and bulk transcriptomics identifies a tumor‐specific CD36+ cancer‐associated fibroblast subpopulation in colorectal cancer	22
Galectin 3‐binding protein (LGALS3BP) depletion attenuates hepatic fibrosis by reducing transforming growth factor‐β1 (TGF‐β1) availability and inhibits hepatocarcinogenesis	22
The E3 ubiquitin ligase HUWE1 acts through the N‐Myc‐DLL1‐NOTCH1 signaling axis to suppress glioblastoma progression	21
Combination of photodynamic therapy and stimulator of interferon genes (STING) agonist inhibits colorectal tumor growth and recurrence	21
Breaking barriers: Smart vaccine platforms for cancer immunomodulation	21
Cover Image, Volume 44, Issue 4	21
Tumor microenvironment signaling and therapeutics in cancer progression	20
Issue Information	20
Enhancement of CAR‐T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins	20
Cover Image, Volume 43, Issue 6	20
Effect of neutrophils on tumor immunity and immunotherapy resistance with underlying mechanisms	20
Ex vivo STAT3 phosphorylation in circulating immune cells: a novel biomarker for early cancer diagnosis and response to anti‐PD‐1 therapy	20
	19
A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessment	19
Single‐cell‐eQTL mapping in circulating immune cells reveals genetic regulation of response‐associated networks in lung cancer immunotherapy	19
Advanced precision modeling reveals divergent responses of hepatocellular carcinoma to combinatorial immunotherapy	19
Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors	18
The regulatory roles and clinical significance of glycolysis in tumor	18
The efficacy and possible mechanisms of immune checkpoint inhibitors in treating non‐small cell lung cancer patients with epidermal growth factor receptor mutation	18
Enhancing sensitivity of triple‐negative breast cancer to DNA‐damaging therapy through chemical inhibition of the m6A methyltransferase METTL3	18
Targeting ferroptosis resistance resensitizes metastatic HR+HER2− breast cancer cells to palbociclib‐hormone therapy	18
Leptin‐mediated suppression of lipoprotein lipase cleavage enhances lipid uptake and facilitates lymph node metastasis in gastric cancer	17
RGS12 inhibits the progression and metastasis of multiple myeloma by driving M1 macrophage polarization and activation in the bone marrow microenvironment	17
	17
Evolution of tumor microenvironment in colorectal liver metastases under treatment stress	17
Issue Information	17
Infection complications in febrile chimeric antigen receptor (CAR)‐T recipients during the peri‐CAR‐T cell treatment period examined using metagenomic next‐generation sequencing (mNGS)	17
Safety and immunogenicity of a third dose of mRNA‐1273 vaccine among cancer patients	16
Ferroptosis in cancer and cancer immunotherapy	16
Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinica	16
Lysosomal TMEM9‐LAMTOR4‐controlled mTOR signaling integrity is required for mammary tumorigenesis	16
Single‐cell atlas reveals a distinct immune profile fostered by T cell‐B cell crosstalk in triple negative breast cancer	16
The SARS‐CoV‐2 spike protein induces lung cancer migration and invasion in a TLR2‐dependent manner	16
Real‐world outcomes of niraparib treatment in patients with ovarian cancer: a multicenter non‐interventional study in China	16
Perivascular localized cells commit erythropoiesis in PDGF‐B‐expressing solid tumors	16
Targeting N4‐acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2‐mediated HMGB2 mRNA translation	16
Tumor‐derived insulin‐like growth factor‐binding protein‐1 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors	16
Proteomic identification of new diagnostic biomarkers of early‐stage cutaneous mycosis fungoides	16
Issue Information	15
Issue Information	15
Diagnostic value of genetic mutation analysis and mutation profiling of cell‐free DNA in intraocular fluid for vitreoretinal lymphoma	14
Discovery of a novel viroid‐like circular RNA in colorectal cancer	14
ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple‐negative breast cancer models	14
	14
Smoking, smoking cessation, and survival after cancer diagnosis in 128,423 patients across cancer types	14
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma	14
Unraveling the routes to distant metastases in colorectal cancer: Tumor deposits and lymph node metastases as the gateway	14
Transient and DNA‐free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis	13
Cover Image, Volume 43, Issue 12	13
NHE7 upregulation potentiates the uptake of small extracellular vesicles by enhancing maturation of macropinosomes in hepatocellular carcinoma	13
Cancer diagnosis is one quarter lower than the expected cancer incidence in the first year of COVID‐19 pandemic in Germany: A retrospective register‐based cohort study	13
Issue Information	13
Efficacy, safety and biomarkers of SG001 for patients with previously treated recurrent or metastatic cervical cancer: an open‐label, multicenter, phase Ib trial	13
Targeted STAT1 therapy for LZTR1‐driven peripheral nerve sheath tumor	13
Combination of anti‐PD‐L1 antibody with peptide MEL‐dKLA targeting M2 tumor‐associated macrophages suppresses breast cancer metastasis	13
Engineering heavy chain antibody‐drug conjugates against solid tumors for a one‐shot kill	12
Issue Information	12
Exciting progress in targeted therapy innovation for unresectable stage III EGFR‐mutated NSCLC: the phase III LAURA study	12
Methionine restriction sensitizes cancer cells to immunotherapy	12
A phase II study on Mefatinib as first‐line treatment of patients with advanced non‐small‐cell lung cancer harboring uncommon EGFR mutations	12
Lung cancer risk score for ever and never smokers in China	11

Combining methylated SEPTIN9 and RNF180 plasma markers for diagnosis and early detection of gastric cancer	11
Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma	11
Combating cancer immunotherapy resistance: a nano‐medicine perspective	11
	10
Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)‐T therapy has potential to reduce escape from single‐target CAR‐T with no more hematotoxicity	10
Cover Image, Volume 43, Issue 9	10
Vascular smooth muscle cell plasticity in the tumor microenvironment	10
Clinical characteristics and outcomes of Chinese patients with KRAS‐mutant non‐small cell lung cancer after chemotherapy	10
Cover Image, Volume 42, Issue 6	10
Nicotinamide N‐methyltransferase negatively regulates metastasis‐promoting property of cancer‐associated fibroblasts in lung adenocarcinoma	10
Lymphatic metastasis in non‐small cell lung cancer: recent discoveries and novel therapeutic targets	10
Dynamic epi‐transcriptomic landscape mapping with disease progression in estrogen receptor‐positive breast cancer	10
	10
Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment	10
Plasma small‐extracellular vesicles enriched in miR‐122‐5p promote disease aggressiveness in pediatric anaplastic large‐cell lymphoma	10
Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor‐associated myocarditis	9
Stereotactic body radiotherapy plus cadonilimab (PD‐1/CTLA‐4 bispecific antibody) as third‐line or beyond therapy for refractory solid tumors: A phase 1b study	9
Issue Information	9
MFSD2A potentiates gastric cancer response to anti‐PD‐1 immunotherapy by reprogramming the tumor microenvironment to activate T cell response	9
	9
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023	9
Transcription factor ETV4 promotes the development of hepatocellular carcinoma by driving hepatic TNF‐α signaling	9
Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2‐positive gastric cancer	9
Training the synergy between Bacillus Calmette‐Guérin and immune checkpoint‐blocking antibodies in bladder cancer	8
Intratumoral CD103+CD8+ T cells predict response to neoadjuvant chemoimmunotherapy in advanced head and neck squamous cell carcinoma	8
Cover Image, Volume 41, Issue 12	8
KRAS‐G12D mutation drives immune suppression and the primary resistance of anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer	8
Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation‐based therapy	8
Loss of ID3 in pancreatic cancer cells increases DNA damage without impairing MDC1 recruitment to the nuclear foci	8
Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple‐negative breast cancer to immune checkpoint inhibitors	8
Targeting MAN1B1 potently enhances bladder cancer antitumor immunity via deglycosylation of CD47	8
Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy	8
Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial	8
Transcriptome‐wide association analysis identified candidate susceptibility genes for nasopharyngeal carcinoma	8
Detection of pancreatic cancer by indocyanine green‐assisted fluorescence imaging in the first and second near‐infrared windows	7
Cover Image, Volume 42, Issue 8	7
Cover Image, Volume 43, Issue 11	7
Dietary intake of advanced glycation endproducts (AGEs) and cancer risk across more than 20 anatomical sites: A multinational cohort study	7
Semaglutide impairs bioavailability of alectinib: a note of warning based on a cross‐over pharmacokinetic drug‐drug interaction study	7
Unveiling quality of clinical trial in China: from concern to confirmation	7
Tumor derived cell‐free nucleic acid upregulates programmed death‐ligand 1 expression in neutrophil via intracellular Toll‐like receptor signaling	7
Cover Image, Volume 42, Issue 6	7
Survival trends of patients with non‐metastatic gastric adenocarcinoma in the US and European countries: the impact of decreasing resection rates	7
Simvastatin overcomes the pPCK1‐pLDHA‐SPRINGlac axis‐mediated ferroptosis and chemo‐immunotherapy resistance in AKT‐hyperactivated intrahepatic cholangiocarcinoma	7
Vitamin D3 for reducing mortality from cancer and other outcomes before, during and beyond the COVID‐19 pandemic: A plea for harvesting low‐hanging fruit	7
	7
Issue Information	7
Identification of telomere maintenance gene variations related to lung adenocarcinoma risk by genome‐wide association and whole genome sequencing analyses	7
Issue Information	6
Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib	6
Parkin deficiency promotes colorectal tumorigenesis and progression through RIPK3‐dependent necroptotic inflammation	6
The interplay between natural killer cells and pancreatic stellate cells in pancreatic ductal adenocarcinoma	6
Comparative risk of acute kidney injury among cancer patients treated with immune checkpoint inhibitors	6
Aberrant translation regulated by METTL1/WDR4‐mediated tRNA N7‐methylguanosine modification drives head and neck squamous cell carcinoma progression	6
Phosphatidylserine released from apoptotic cells in tumor induces M2‐like macrophage polarization through the PSR‐STAT3‐JMJD3 axis	6
Neutrophils in cancer: At the crucial crossroads of anti‐tumor and pro‐tumor	6
	6
Converting “cold” to “hot”: epigenetics strategies to improve immune therapy effect by regulating tumor‐associated immune suppressive cells	6
NAT10 regulates tumor progression and immune microenvironment in pancreatic ductal adenocarcinoma via the N4‐acetylated LAMB3‐mediated FAK/ERK pathway	6
A serum exosomal microRNA‐based artificial intelligence diagnostic model for highly accurate detection of hepatocellular carcinoma	6
Dysfunction of dendritic cells in tumor microenvironment and immunotherapy	6
	6
Issue Information	6
Helicobacter pylori CagA elevates FTO to induce gastric cancer progression via a “hit‐and‐run” paradigm	6
A novel intronic circular RNA, circGNG7, inhibits head and neck squamous cell carcinoma progression by blocking the phosphorylation of heat shock protein 27 at Ser78 and Ser82	6
Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1	6
Serologic status and safety of inactivated Covid‐19 vaccine for hepatocellular carcinoma patients with cirrhosis after curative liver resection	6
Fusobacterium is toxic for head and neck squamous cell carcinoma and its presence may determine a better prognosis	6
Single whole‐genome sequencing analysis of metastatic biopsy is sufficient for investigational treatment opportunities in cancer	6
Issue Information	6
Front Cover: Nuclear Aurora kinase A triggers programmed death‐ligand 1‐mediated immune suppression by activating MYC transcription in triple‐negative breast cancer	5
miR‐99a‐5p modulates doxorubicin resistance via the COX‐2/ABCG2 axis in triple‐negative breast cancer: from the discovery to in vivo studies	5
A non‐metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11‐mediated CD133 stability	5
Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy	5
SALIRI‐based (raltitrexed plus irinotecan) therapy as a second‐line treatment for patients with metastatic colorectal cancer (SALLY): A prospective, multicenter, non‐interventional, registry study	5
Exposure of benzo[a]pyrene induces HCC exosome‐circular RNA to activate lung fibroblasts and trigger organotropic metastasis	5
Targeted reactivation of the novel tumor suppressor DAPK1, an upstream regulator of p53, in high‐grade serous ovarian cancer by mRNA liposomes reduces viability and enhances drug sensitivity in precli	5
Issue Information	5
Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21‐mediated ubiquitination/degradation of STAT1 in a GTP binding‐dependent modality	5
“Find Me” and “Eat Me” signals: tools to drive phagocytic processes for modulating antitumor immunity	5
NAT10‐mediated ac4C‐modified ANKZF1 promotes tumor progression and lymphangiogenesis in clear‐cell renal cell carcinoma by attenuating YWHAE‐driven cytoplasmic retention of YAP1	5
Dual inhibition of sirtuins 1 and 2: reprogramming metabolic energy dynamics in chronic myeloid leukemia as an immunogenic anticancer strategy	5
m6A‐mediated regulation of PBX1‐GCH1 axis promotes gastric cancer proliferation and metastasis by elevating tetrahydrobiopterin levels	5
ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor‐negative breast cancer patients	5
	5
Non‐small cell lung cancer in China	5
Enhancing antitumor immunity through the combination of cholesterolized TLR7 agonist liposomes and radiotherapy: a role for IL‐1β and the inflammasome pathway	5
Single‐cell transcriptomic analysis uncovers intratumoral heterogeneity and drug‐tolerant persister in ALK‐rearranged lung adenocarcinoma	5
Issue Information	5
Single‐cell multi‐omics reveals tumor microenvironment factors underlying poor immunotherapy responses in ALK‐positive lung cancer	5
Evaluation of exposure‐response‐safety relationship of model‐informed low‐dose 500 mg abiraterone acetate in prostate cancer patients	5
Activation mechanisms of clinically distinct B‐Raf V600E and V600K mutants	5
Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER‐positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor	4
Resistance to antibody‐drug conjugates in breast cancer: mechanisms and solutions	4
Unraveling the effects of screening colonoscopy on colorectal cancer early detection and prevention: the NordICC trial revisited	4